A Study of mRNA-2808 in Participants With Relapsed or Refractory Multiple Myeloma
Clinical trial NCT07116616 · RECRUITING
Trial details
- NCT number
- NCT07116616
- Sponsor
- ModernaTX, Inc.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-30
- Primary completion
- 2030-06-17
- Enrollment
- 166
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.